EUCTR2007-000451-34-IT进行中（未招募）不适用
Therapy of hyperhomocysteinemia in hemodialysis patients:effects of acetylcysteine and folates. - ND
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI0 个研究点开始时间: 2010年9月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Chronic uremic patients undergoing hemodialysis therapy will be recruited among Chronic Hemodialysis Centers. Clinically stable patients will be selected, undergoing hemodialysis since more than three months, provided that they will not be affected by systemic diseases such as cancer, lupus erythematosus, etc. Patients, if receiving folate therapy, will undergo a washout period of two months.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Sistemic diseases, such as cancer, lupus, etc.
研究者
相似试验
已完成
2 期
Homeopathic medicines for high uric acid levels in bloodCTRI/2022/04/041991The Calcutta Homoeopathic Medical College and Hospital60
已完成
不适用
Evaluation of calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism: a real-world observational studyHemodialysis patients with secondary hyperparathyroidismJPRN-UMIN000030354Ono Pharmaceutical Co.,ltd.3,000
进行中（未招募）
不适用
Cysteamine Hydrochloride for nephrOpathic Cystinosis, open-label Phase III pivotal studyEUCTR2009-012564-13-FROrphan Europe SAR
已完成
不适用
utritional intervention for hemodialysis patients with locomotive syndromelocomotive syndrome hemodialysisJPRN-UMIN000032457Shinkohkai Murakamikinen Hospital Department of Nutrition40
招募中
不适用
Potassium handling in chronic hemodialysis patients in response to higher dialysate potassiumCKD-5DEnd-Stage-Renal-Disease10029149NL-OMON55533Academisch Medisch Centrum30